AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

The Microbiome in Dermatology

Description

The presentation focuses on the significant role of the microbiome in dermatology, particularly how it interacts with the immune system and influences skin diseases. The speaker discusses the concept of microbiota, which refers to the diverse microorganisms inhabiting various parts of the body, and emphasizes that they can be beneficial, harmless, or harmful depending on context. Emerging research suggests that microbes can stimulate autoimmunity, such as lupus, through mechanisms like molecular mimicry or bacterial translocation, leading to immune dysregulation. The speaker highlights fascinating connections between the microbiome and melanoma immunotherapy, where gut bacteria composition can influence patient responses to treatment. Important findings from studies show that antibiotics negatively impact survival rates in melanoma patients receiving immunotherapy, while dietary interventions, particularly high-fiber diets, can promote favorable outcomes. Probiotic use is cautioned against, with indications that they may even exacerbate conditions. The presentation concludes with the notion that maintaining a healthy microbiome through a balanced diet can support the immune system and potentially prevent or manage autoimmune diseases.

View more

Conclusions

  • Microbial biodiversity is essential for maintaining a healthy and functional immune system.
  • Exposure to commensal and pathogenic microbes during early life helps prevent autoimmune and inflammatory diseases.
  • Dysbiosis, or an imbalance of gut microbes, is linked to immune dysregulation and may trigger autoimmune diseases.
  • Certain microbes can stimulate autoimmunity through mechanisms like molecular mimicry and bacterial translocation.
  • Autoimmune diseases like lupus and rheumatoid arthritis may be perpetuated by commensal microbes that mimic human proteins, leading to cross-reactivity.
  • Fecal microbiota transplantation has shown promise in treating autoimmune diseases and improving responses to immunotherapy.
  • High-fiber diets can enhance the efficacy of melanoma immunotherapy, while probiotics may be detrimental in this context.
  • Dietary restrictions and consuming prebiotic-rich foods can help reshape the microbiota and reduce inflammatory responses.
  • Antibiotic use during immunotherapy can negatively affect patient survival rates in melanoma treatment.
  • The relationship between diet, microbial diversity, and immune function is complex, necessitating further research to identify effective dietary interventions.
  • Ruff, Greiling, and Kriegel (2020) Host-microbiota interactions in immune-mediated diseases. Nat. Rev. Microbiol. 2020 Sep;18(9):521-538.
  • Greiling TM, Kriegel MA. "Immunopathogenesis: the role of mucosal and skin microbiota in SLE." Lahita's Systemic Lupus Erythematosus, 6th edition. Elsevier, 2021. Print.
  • Azzouz D, Omarbekova A, Heguy A, et al. Ruminococcus gnavus lipoglycan links lupus nephritis to disease-activity associated expansions in immunity to a gut commensal. Ann Rheum Dis. 2019 Jul;78(7):947-956. doi: 10.1136/annrheumdis-2018-214856.
  • Ruff WE, Dehner C, Kim WJ, et al. Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity. Cell Host Microbe. 2019 Jul 10;26(1):100-113.e8. doi: 10.1016/j.chom.2019.05.003.
  • Liu H, et al. A Randomized Clinical Trial of fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis. BMC Microbiol. 2023 Nov 29;23(1):371. doi: 10.1186/s12866-023-03107-1.
  • Huang C, et al. Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial. J Autoimmun. 2022 Jun;130:102844. doi: 10.1016/j.jaut.2022.102844.
  • Zhou J, et al. The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors. Front Immunol. 2022 Jul 28;13:968729. doi: 10.3389/fimmu.2022.968729.
  • Gopalakrishnan et al., Science 2021.
  • Matson et al., Science 2018.
  • Routy et al., Science 2018.